FindTrial
Sign In

Based on electroanatomical feature for superior venous isolation combined with circumferential pulmonary vein isolation on the success of radiofrequency ablation in patients with paroxysmal atrial fibrillation: a prospective study

Based on electroanatomical feature for superior venous isolation combined with circumferential pulmonary vein isolation on the success of radiofrequency ablation in patients with paroxysmal atrial fibrillation: a prospective study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034532
Enrollment
Unknown
Registered
2020-07-08
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

Group 1:Pulmonary vein isolation combined with superior vena cava isolation
Group 2:pulmonary vein isolation

Sponsors

The First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with paroxysmal atrial fibrillation; 2. Men and women are not limited; 3. Aged 18-75 years; 4. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Left atrial thrombus; 2. Left atrial diameter > 50mm; 3. Patients with recurrent atrial fibrillation; 4. Hyperthyroidism and hypothyroidism in the treatment period; 5. Severe cerebral infarction; 6. Diseases of blood system; 7. Severe hepatic and renal insufficiency; 8. Pregnant or lactating women; 9. Psychopath; 10. Life expectancy < 1 year.

Design outcomes

Primary

MeasureTime frame
Recurrence of atrial fibrillation;—

Secondary

MeasureTime frame
Complication;—

Countries

China

Contacts

Public ContactFengxiang Zhang

The First Affiliated Hospital of Nanjing Medical University

chenxinguang.gy@163.com+86 18397872715

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026